A. Boschini

发表

Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users.

P. Pezzotti, G. Rezza, E. Pozio, 1997, The Journal of infectious diseases.

Coinfection With HIV-1 and Human T-Cell Lymphotropic Virus Type II in Intravenous Drug Users Is Associated With Delayed Progression to AIDS

A. Lisa, A. Boschini, S. Parisi, 2006, Journal of acquired immune deficiency syndromes.

Cutaneous side effects induced by indinavir.

A. Boschini, D. Calista, 1998, European journal of dermatology : EJD.

Influenza vaccination of HIV‐1‐positive and hiv‐1‐negative former intravenous drug users

E. Tanzi, A. Zanetti, A. Amendola, 2001, Journal of medical virology.

L-Carnitine, a Modulator of Immunometabolic Homeostasis in Subjects Infected with the Human Immunodeficiency Virus

S. Moretti, A. Boschini, G. Famularo, 1997 .

Safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine in HIV-1 infected former drug users.

D. Musher, E. Tanzi, A. Zanetti, 2002, Vaccine.

Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspects.

G. Castellani, A. Lepri, G. Rezza, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cancer risk among men with, or at risk of, HIV infection in southern Europe

S. Franceschi, G. Ippolito, D. Serraino, 2000, AIDS.

The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: Study of 43 cases with review of the literature

A. Lazzarin, A. Campi, P. Cinque, 2011, Journal of NeuroVirology.

The incidence of Cytomegalovirus (CMV) antigenemia and CMV disease is reduced by highly active antiretroviral therapy

R. Manfredi, F. Chiodo, T. Lazzarotto, 2000, European Journal of Epidemiology.

Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

L. Sticchi, A. Parodi, F. Ansaldi, 2007, Clinical and Vaccine Immunology.

Safety and immunogenicity of influenza vaccination in individuals infected with HIV.

E. Tanzi, A. Zanetti, A. Amendola, 2002, Vaccine.

1-Seropositive and -Seronegative Adults Human Immunodeficiency Virus Type without MF59 Adjuvant, Administered to Influenza Virus Subunit Vaccines, with or Safety and Immunogenicity of Two

L. Sticchi, F. Ansaldi, G. Icardi, 2013 .

Outbreak of Chlamydia pneumoniae infection in former injection-drug users.

F. Blasi, L. Allegra, A. Boschini, 1994, Chest.

Cell-associated ceramide in HIV-1-infected subjects.

S. Steinberg, R. Testi, S. Moretti, 1996, AIDS (London).

Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.

A. Lazzarin, P. Cinque, S. Bossolasco, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Absence of hepatitis C virus and detection of hepatitis G virus/GB virus C RNA sequences in the semen of infected men.

G. Pardi, C. Bréchot, A. Boschini, 1998, The Journal of infectious diseases.

Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy

C. Yiannoutsos, A. Lazzarin, B. Musick, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immigration, HIV infection, and sexually transmitted diseases in Europe.

G. di Perri, A. Boschini, C. Smacchia, 2000, AIDS patient care and STDs.

Response to 2009 pandemic and seasonal influenza vaccines co-administered to HIV-infected and HIV-uninfected former drug users living in a rehabilitation community in Italy.

E. Pariani, A. Zanetti, A. Amendola, 2011, Vaccine.

Consecutive epidemics of Q fever in a residential facility for drug abusers: impact on persons with human immunodeficiency virus infection.

G. di Perri, G. Rezza, A. Boschini, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HTLV-II among Italian intravenous drug users and hemophiliacs

C. Galli, A. Zanetti, E. Tanzi, 1992, European Journal of Epidemiology.

Effect of L-carnitine on human immunodeficiency virus-1 infection-associated apoptosis: a pilot study.

S. Steinberg, S. Moretti, C. De Simone, 1998, Blood.

Suboptimal response to hepatitis B vaccine in drug users.

A. Zanetti, P. Mannucci, A. Boschini, 1991, Archives of internal medicine.

Eyelid nodule: a sentinel lesion of disseminated cryptococcosis in a patient with acquired immunodeficiency syndrome.

A. Boschini, D. Calista, L. Coccia, 1999, Archives of ophthalmology.

Disseminated rhodococcus equi infection in HIV infection despite highly active antiretroviral therapy

A. Lazzarin, P. Cinque, G. Balconi, 2011, BMC infectious diseases.

L-carnitine reduces lymphocyte apoptosis and oxidant stress in HIV-1-infected subjects treated with zidovudine and didanosine.

S. Moretti, C. De Simone, E. Alesse, 2002, Antioxidants & redox signaling.

Apoptosis and apoptosis‐associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long‐term non‐progressors

S. Steinberg, G. Kroemer, S. Moretti, 2000, Clinical and experimental immunology.

HPV, HIV infection, and risk of cervical intraepithelial neoplasia in former intravenous drug abusers.

E. Negri, F. Parazzini, A. Agarossi, 1993, Gynecologic oncology.

Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis.

S. Moretti, C. De Simone, L. di Marzio, 1999, Immunopharmacology and immunotoxicology.

Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities.

A. Soddu, G. Rezza, S. Carbonara, 2011, AIDS patient care and STDs.

Infection with Human Herpesvirus Type-8 among Foreign Female Sex Workers in Italy

D. Serraino, P. Piselli, F. Carletti, 2004, Infection.

Mortality among drug users in the AIDS era.

J. Goedert, A. Boschini, P. Costigliola, 1995, International journal of epidemiology.

Phenotypic characteristics and tendency to apoptosis of peripheral blood mononuclear cells from HIV+ long term non progressors

G. Castellani, C. Franceschi, T. Trenti, 1997, Cell Death and Differentiation.

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

M. Peluso, D. Fuchs, R. Price, 2012, AIDS.

SARS-CoV-2 Specific Immune Response and Inflammatory Profile in Advanced HIV-Infected Persons during a COVID-19 Outbreak

C. Agrati, E. Cimini, C. Castilletti, 2022, Viruses.

Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.

A. Boschini, D. Calista, G. Landi, 1999, European journal of dermatology : EJD.

An outbreak of influenza in a residential drug‐rehabilitation community

F. Ansaldi, P. Durando, G. Icardi, 2006, Journal of medical virology.

Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients

L. Barbara, A. Boschini, J. Holton, 1995, Digestive Diseases and Sciences.

Ceramide, AIDS and long-term survivors.

R. Testi, S. Moretti, C. De Simone, 1996, Immunology today.

Changing Morbidity of Cutaneous Diseases in Patients with HIV After the Introduction of Highly Active Antiretroviral Therapy Including a Protease Inhibitor

A. Boschini, D. Calista, A. Stagno, 2002, American journal of clinical dermatology.